OtherChemotherapy, Antibiotics, and Gene Therapy
Design and evaluation of S-nitrosylated human serum albumin (SNO-HSA) as a novel anticancer drug
Naohisa Katayama, Keisuke Nakajou, Hisakazu Komori, Kunitoshi Uchida, Jun-ichi Yokoe, Norikiyo Yasui, Hisashi Yamamoto, Toshiya Kai, Makoto Sato, Takenobu Nakagawa, Motohiro Takeya, Toru Maruyama and Masaki Otagiri
Journal of Pharmacology and Experimental Therapeutics January 24, 2008, DOI: https://doi.org/10.1124/jpet.107.132100
Naohisa Katayama
Keisuke Nakajou
Hisakazu Komori
Kunitoshi Uchida
Jun-ichi Yokoe
Norikiyo Yasui
Hisashi Yamamoto
Toshiya Kai
Makoto Sato
Takenobu Nakagawa
Motohiro Takeya
Toru Maruyama
Jump to comment:
No eLetters have been published for this article.
In this issue
OtherChemotherapy, Antibiotics, and Gene Therapy
Design and evaluation of S-nitrosylated human serum albumin (SNO-HSA) as a novel anticancer drug
Naohisa Katayama, Keisuke Nakajou, Hisakazu Komori, Kunitoshi Uchida, Jun-ichi Yokoe, Norikiyo Yasui, Hisashi Yamamoto, Toshiya Kai, Makoto Sato, Takenobu Nakagawa, Motohiro Takeya, Toru Maruyama and Masaki Otagiri
Journal of Pharmacology and Experimental Therapeutics January 24, 2008, DOI: https://doi.org/10.1124/jpet.107.132100
OtherChemotherapy, Antibiotics, and Gene Therapy
Design and evaluation of S-nitrosylated human serum albumin (SNO-HSA) as a novel anticancer drug
Naohisa Katayama, Keisuke Nakajou, Hisakazu Komori, Kunitoshi Uchida, Jun-ichi Yokoe, Norikiyo Yasui, Hisashi Yamamoto, Toshiya Kai, Makoto Sato, Takenobu Nakagawa, Motohiro Takeya, Toru Maruyama and Masaki Otagiri
Journal of Pharmacology and Experimental Therapeutics January 24, 2008, DOI: https://doi.org/10.1124/jpet.107.132100
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement